Tirasemtiv Completed Phase 2 Trials for Intermittent Claudication / Peripheral Arterial Disease (PAD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01131013A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication